6 - (IOP 22) What Counts as Evidence in Suicide Prevention? Rethinking Outcomes, Impact, and Implementation

Suicide prevention remains a critical yet challenging area of intervention science. While cognitive and behavioral therapies (CBTs) have contributed substantially to evidence-based approaches, questions persist about how best to define and evaluate meaningful progress. As suicide behavior has a low base rate and is difficult to power for in clinical trials, especially within short timeframes, the field must reflect on what outcomes are most relevant, feasible, and impactful to measure. Suicide prevention science sits at a critical inflection point—one that calls for thoughtful consideration of how evidence is generated, interpreted, and translated into practice.

Standards for evaluating suicide prevention interventions have varied. Given the base rate problem, suicidal ideation has often served as an outcome in research. Some data suggest ideation is not strongly predictive of suicidal behavior. Despite this, many argue it remains important to measure and track over time due to its clinical relevance. Many trials assess suicide-related outcomes using non-suicide-specific measures, often as secondary endpoints. Meanwhile, suicide-specific therapies emphasize behavioral outcomes as a primary focus. Each perspective offers value, but without a cohesive framework, it remains unclear whether current outcomes truly capture impact or merely reflect what is most feasible to measure. A more deliberate approach is needed to determine whether interventions effectively reduce risk or if we are measuring constructs that may not translate to meaningful real-world impact.

Suicide-specific CBT interventions—such as Brief Cognitive Behavioral Therapy (BCBT) and Cognitive Therapy for Suicide Prevention (CT-SP)—were designed to target suicidal behavior and have demonstrated effectiveness in reducing both behavioral outcomes and broader mental health symptoms. However, they remain underutilized in systems serving high-risk populations. If suicidal behavior is the most critical outcome in prevention science, greater attention to implementing interventions designed to address it may be warranted. At the same time, questions remain about how treatment designation and evidence standards account for interventions targeting rare but high-impact outcomes. These complexities must be considered as the field seeks to bridge scientific development and system-level adoption.

This presentation will explore the evolving landscape of suicide prevention research, focusing on how conceptualizing meaningful outcomes influences implementation readiness. It will consider how diverse evidence sources—including behavioral, cognitive, psychosocial, and lived experience perspectives—can inform a more comprehensive understanding of intervention impact. It will also highlight the importance of outcome frameworks that support personalized care, translational relevance, and implementation feasibility.

Ultimately, this talk aims to foster a thoughtful dialogue within the CBT community: not to lower the bar for evidence, but to ensure that the way we define success reflects the full range of interventions that can reduce suffering, promote recovery, and, in many cases, save lives.